Bausch + Lomb (BLCO) Q3 2025 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]
Bausch + Lomb Corporation Common Shares (BLCO)
Company Research
Source: Globe and Mail, The
Chief Financial Officer — Osama Eldessouky Chief Medical Officer and Head of Research & Development — Yehia Hashad Need a quote from a Motley Fool analyst? Email pr@fool.com Takeaways Total revenue -- $1.281 billion, reflecting 6% year-over-year growth and a $19 million currency benefit. Vision care segment revenue -- $736 million, up 6%, with balanced growth in consumer and contact lenses. Contact lenses revenue -- 6% growth, outpacing the market; U.S. contact lens sales rose 9%, international grew 4%. Daily SiHy contact lenses -- 24% increase in revenue, leading segment growth. Consumer dry eye portfolio -- $113 million revenue, 18% higher, with Blink up 36% and Artelac up 18%. LUMIFY revenue -- $48 million, a 2% increase, with year-to-date growth of 13%. Eye vitamins -- 11% revenue increase for PreserVision and Ocuvite; 12% overall growth for the category. Surgical segment revenue -- $215 million, up 1%; when adjusting for enVista recall, 7% growth achieved.
Show less
Read more
Impact Snapshot
Event Time:
BLCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLCO alerts
High impacting Bausch + Lomb Corporation Common Shares news events
Weekly update
A roundup of the hottest topics
BLCO
News
- Why Bausch + Lomb (BLCO) Just Strengthened Something Beyond Earnings [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb (BLCO) Q4 2025 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Bausch + Lomb (BLCO) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=BLCO&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" to "MarketBeat
- Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling ProgramBusiness Wire
- Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update [Yahoo! Finance]Yahoo! Finance
BLCO
Earnings
- 2/18/26 - Miss
BLCO
Sec Filings
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- BLCO's page on the SEC website